Antidepressant Medication Treatment Failure Does Not Predict Lower Remission With ECT for Major Depressive Disorder: A Report From the Consortium for Research in Electroconvulsive Therapy

Keith G. Rasmussen, MD; Martina Mueller, PhD; Rebecca G. Knapp, PhD; Mustafa M. Husain, MD; Teresa A. Rummans, MD; Shirlene M. Sampson, MD; M. Kevin O'Connor, MD; Georgios Petrides, MD; Max Fink, MD, and Charles H. Kellner, MD

Published: November 15, 2007

Article Abstract

Objective: To test whether antidepressant medication treatment failure predicts differential remission with electroconvulsive therapy (ECT) in nonpsychotic unipolar depression.

Method: Depressed patients diagnosed with the Structured Clinical Interview for DSM-IV receiving ECT were assessed for medication use with the Antidepressant Treatment History Form (ATHF) (N = 345). Response to ECT was assessed with the 24-item Hamilton Rating Scale for Depression. Baseline medication treatment failure was analyzed as a possible predictor of remission status. Dates of study enrollment were from May 1997 to July 2004.

Results: Resistance to antidepressant medication as assessed by the ATHF, either taken as a whole or for any individual class of medication, was not predictive of acute remission status with ECT.

Conclusion: Treatment failure with antidepressant medication does not predict acute remission status with ECT for nonpsychotically depressed patients.

Volume: 68

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...